English
简体中文
Total: £ 56.28
Published Date: 2025-01-03 | Pages: 71 | Tables: 69 | Pharma & Healthcare
The global market for Tumor Necrosis Factor Receptor Superfamily Member 1A was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Tumor Necrosis Factor Receptor Superfamily Member 1A is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tumor Necrosis Factor Receptor Superfamily Member 1A is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Tumor Necrosis Factor Receptor Superfamily Member 1A include Addex Therapeutics Ltd, G&E Herbal Biotechnology Co., Ltd., GlaxoSmithKline Plc, Inflamalps SA, Polaris Pharmaceuticals, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tumor Necrosis Factor Receptor Superfamily Member 1A, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Necrosis Factor Receptor Superfamily Member 1A.
The Tumor Necrosis Factor Receptor Superfamily Member 1A market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor Necrosis Factor Receptor Superfamily Member 1A market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Necrosis Factor Receptor Superfamily Member 1A manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Addex Therapeutics Ltd
G&E Herbal Biotechnology Co., Ltd.
GlaxoSmithKline Plc
Inflamalps SA
Polaris Pharmaceuticals, Inc.
Segment by Type
LY-3232094
EYS-606
SRT-100
Others
Segment by Application
Genital Warts
Melanoma
Multiple Sclerosis
Psoriasis
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tumor Necrosis Factor Receptor Superfamily Member 1A manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tumor Necrosis Factor Receptor Superfamily Member 1A in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Overview
1.1 Product Definition
1.2 Tumor Necrosis Factor Receptor Superfamily Member 1A by Type
1.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Value Comparison by Type (2024 VS 2031)
1.2.2 LY-3232094
1.2.3 EYS-606
1.2.4 SRT-100
1.2.5 Others
1.3 Tumor Necrosis Factor Receptor Superfamily Member 1A by Application
1.3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Value by Application (2024 VS 2031)
1.3.2 Genital Warts
1.3.3 Melanoma
1.3.4 Multiple Sclerosis
1.3.5 Psoriasis
1.3.6 Others
1.4 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size Estimates and Forecasts
1.4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue 2020-2031
1.4.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales 2020-2031
1.4.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Competition by Manufacturers
2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tumor Necrosis Factor Receptor Superfamily Member 1A, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tumor Necrosis Factor Receptor Superfamily Member 1A, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tumor Necrosis Factor Receptor Superfamily Member 1A, Product Type & Application
2.7 Global Key Manufacturers of Tumor Necrosis Factor Receptor Superfamily Member 1A, Date of Enter into This Industry
2.8 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Competitive Situation and Trends
2.8.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tumor Necrosis Factor Receptor Superfamily Member 1A Players Market Share by Revenue
2.8.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Scenario by Region
3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Region: 2020-2031
3.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Region: 2020-2025
3.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Region: 2026-2031
3.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Region: 2020-2031
3.3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Region: 2020-2025
3.3.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Region: 2026-2031
3.4 North America Tumor Necrosis Factor Receptor Superfamily Member 1A Market Facts & Figures by Country
3.4.1 North America Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2020-2031)
3.4.3 North America Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Market Facts & Figures by Country
3.5.1 Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2020-2031)
3.5.3 Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Market Facts & Figures by Region
3.6.1 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Region (2020-2031)
3.6.3 Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Market Facts & Figures by Country
3.7.1 Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2020-2031)
3.7.3 Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Market Facts & Figures by Country
3.8.1 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type (2020-2031)
4.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type (2020-2025)
4.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type (2026-2031)
4.1.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type (2020-2031)
4.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Type (2020-2031)
4.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Type (2020-2025)
4.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Type (2026-2031)
4.2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Market Share by Type (2020-2031)
4.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2020-2031)
5.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2020-2025)
5.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Application (2026-2031)
5.1.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application (2020-2031)
5.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Application (2020-2031)
5.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Application (2020-2025)
5.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Application (2026-2031)
5.2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Market Share by Application (2020-2031)
5.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Addex Therapeutics Ltd
6.1.1 Addex Therapeutics Ltd Company Information
6.1.2 Addex Therapeutics Ltd Description and Business Overview
6.1.3 Addex Therapeutics Ltd Tumor Necrosis Factor Receptor Superfamily Member 1A Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Addex Therapeutics Ltd Tumor Necrosis Factor Receptor Superfamily Member 1A Product Portfolio
6.1.5 Addex Therapeutics Ltd Recent Developments/Updates
6.2 G&E Herbal Biotechnology Co., Ltd.
6.2.1 G&E Herbal Biotechnology Co., Ltd. Company Information
6.2.2 G&E Herbal Biotechnology Co., Ltd. Description and Business Overview
6.2.3 G&E Herbal Biotechnology Co., Ltd. Tumor Necrosis Factor Receptor Superfamily Member 1A Sales, Revenue and Gross Margin (2020-2025)
6.2.4 G&E Herbal Biotechnology Co., Ltd. Tumor Necrosis Factor Receptor Superfamily Member 1A Product Portfolio
6.2.5 G&E Herbal Biotechnology Co., Ltd. Recent Developments/Updates
6.3 GlaxoSmithKline Plc
6.3.1 GlaxoSmithKline Plc Company Information
6.3.2 GlaxoSmithKline Plc Description and Business Overview
6.3.3 GlaxoSmithKline Plc Tumor Necrosis Factor Receptor Superfamily Member 1A Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GlaxoSmithKline Plc Tumor Necrosis Factor Receptor Superfamily Member 1A Product Portfolio
6.3.5 GlaxoSmithKline Plc Recent Developments/Updates
6.4 Inflamalps SA
6.4.1 Inflamalps SA Company Information
6.4.2 Inflamalps SA Description and Business Overview
6.4.3 Inflamalps SA Tumor Necrosis Factor Receptor Superfamily Member 1A Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Inflamalps SA Tumor Necrosis Factor Receptor Superfamily Member 1A Product Portfolio
6.4.5 Inflamalps SA Recent Developments/Updates
6.5 Polaris Pharmaceuticals, Inc.
6.5.1 Polaris Pharmaceuticals, Inc. Company Information
6.5.2 Polaris Pharmaceuticals, Inc. Description and Business Overview
6.5.3 Polaris Pharmaceuticals, Inc. Tumor Necrosis Factor Receptor Superfamily Member 1A Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Polaris Pharmaceuticals, Inc. Tumor Necrosis Factor Receptor Superfamily Member 1A Product Portfolio
6.5.5 Polaris Pharmaceuticals, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tumor Necrosis Factor Receptor Superfamily Member 1A Industry Chain Analysis
7.2 Tumor Necrosis Factor Receptor Superfamily Member 1A Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tumor Necrosis Factor Receptor Superfamily Member 1A Production Mode & Process Analysis
7.4 Tumor Necrosis Factor Receptor Superfamily Member 1A Sales and Marketing
7.4.1 Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Channels
7.4.2 Tumor Necrosis Factor Receptor Superfamily Member 1A Distributors
7.5 Tumor Necrosis Factor Receptor Superfamily Member 1A Customer Analysis
8 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Dynamics
8.1 Tumor Necrosis Factor Receptor Superfamily Member 1A Industry Trends
8.2 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Drivers
8.3 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Challenges
8.4 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Competitive Situation by Manufacturers in 2024
Table 4. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Tumor Necrosis Factor Receptor Superfamily Member 1A Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Tumor Necrosis Factor Receptor Superfamily Member 1A, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tumor Necrosis Factor Receptor Superfamily Member 1A, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tumor Necrosis Factor Receptor Superfamily Member 1A, Product Type & Application
Table 12. Global Key Manufacturers of Tumor Necrosis Factor Receptor Superfamily Member 1A, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tumor Necrosis Factor Receptor Superfamily Member 1A by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Necrosis Factor Receptor Superfamily Member 1A as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Region (2020-2025) & (K Units)
Table 18. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Region (2020-2025)
Table 19. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Region (2026-2031) & (K Units)
Table 20. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Region (2026-2031)
Table 21. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Market Share by Region (2020-2025)
Table 23. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Market Share by Region (2026-2031)
Table 25. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2020-2025) & (K Units)
Table 27. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2026-2031) & (K Units)
Table 28. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2020-2025) & (K Units)
Table 32. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2026-2031) & (K Units)
Table 33. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Type (2020-2025)
Table 51. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Type (2026-2031)
Table 52. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type (2020-2025)
Table 53. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type (2026-2031)
Table 54. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Market Share by Type (2020-2025)
Table 57. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Market Share by Type (2026-2031)
Table 58. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price (USD/Unit) by Type (2020-2025)
Table 59. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price (USD/Unit) by Type (2026-2031)
Table 60. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Application (2020-2025)
Table 61. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Application (2026-2031)
Table 62. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application (2020-2025)
Table 63. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application (2026-2031)
Table 64. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Market Share by Application (2020-2025)
Table 67. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Market Share by Application (2026-2031)
Table 68. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price (USD/Unit) by Application (2020-2025)
Table 69. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price (USD/Unit) by Application (2026-2031)
Table 70. Addex Therapeutics Ltd Company Information
Table 71. Addex Therapeutics Ltd Description and Business Overview
Table 72. Addex Therapeutics Ltd Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Addex Therapeutics Ltd Tumor Necrosis Factor Receptor Superfamily Member 1A Product
Table 74. Addex Therapeutics Ltd Recent Developments/Updates
Table 75. G&E Herbal Biotechnology Co., Ltd. Company Information
Table 76. G&E Herbal Biotechnology Co., Ltd. Description and Business Overview
Table 77. G&E Herbal Biotechnology Co., Ltd. Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. G&E Herbal Biotechnology Co., Ltd. Tumor Necrosis Factor Receptor Superfamily Member 1A Product
Table 79. G&E Herbal Biotechnology Co., Ltd. Recent Developments/Updates
Table 80. GlaxoSmithKline Plc Company Information
Table 81. GlaxoSmithKline Plc Description and Business Overview
Table 82. GlaxoSmithKline Plc Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. GlaxoSmithKline Plc Tumor Necrosis Factor Receptor Superfamily Member 1A Product
Table 84. GlaxoSmithKline Plc Recent Developments/Updates
Table 85. Inflamalps SA Company Information
Table 86. Inflamalps SA Description and Business Overview
Table 87. Inflamalps SA Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Inflamalps SA Tumor Necrosis Factor Receptor Superfamily Member 1A Product
Table 89. Inflamalps SA Recent Developments/Updates
Table 90. Polaris Pharmaceuticals, Inc. Company Information
Table 91. Polaris Pharmaceuticals, Inc. Description and Business Overview
Table 92. Polaris Pharmaceuticals, Inc. Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Polaris Pharmaceuticals, Inc. Tumor Necrosis Factor Receptor Superfamily Member 1A Product
Table 94. Polaris Pharmaceuticals, Inc. Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Tumor Necrosis Factor Receptor Superfamily Member 1A Distributors List
Table 98. Tumor Necrosis Factor Receptor Superfamily Member 1A Customers List
Table 99. Tumor Necrosis Factor Receptor Superfamily Member 1A Market Trends
Table 100. Tumor Necrosis Factor Receptor Superfamily Member 1A Market Drivers
Table 101. Tumor Necrosis Factor Receptor Superfamily Member 1A Market Challenges
Table 102. Tumor Necrosis Factor Receptor Superfamily Member 1A Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Tumor Necrosis Factor Receptor Superfamily Member 1A
Figure 2. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Share by Type: 2024 & 2031
Figure 4. LY-3232094 Product Picture
Figure 5. EYS-606 Product Picture
Figure 6. SRT-100 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Share by Application: 2024 & 2031
Figure 10. Genital Warts
Figure 11. Melanoma
Figure 12. Multiple Sclerosis
Figure 13. Psoriasis
Figure 14. Others
Figure 15. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size (2020-2031) & (US$ Million)
Figure 17. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (2020-2031) & (K Units)
Figure 18. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Average Price (USD/Unit) & (2020-2031)
Figure 19. Tumor Necrosis Factor Receptor Superfamily Member 1A Report Years Considered
Figure 20. Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Share by Manufacturers in 2024
Figure 21. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Tumor Necrosis Factor Receptor Superfamily Member 1A Players: Market Share by Revenue in Tumor Necrosis Factor Receptor Superfamily Member 1A in 2024
Figure 23. Tumor Necrosis Factor Receptor Superfamily Member 1A Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Country (2020-2031)
Figure 26. North America Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Country (2020-2031)
Figure 30. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Market Share by Country (2020-2031)
Figure 31. Germany Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Market Share by Region (2020-2031)
Figure 38. China Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Taiwan Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Philippines Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Country (2020-2031)
Figure 49. Latin America Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. U.A.E Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Tumor Necrosis Factor Receptor Superfamily Member 1A by Type (2020-2031)
Figure 59. Global Revenue Market Share of Tumor Necrosis Factor Receptor Superfamily Member 1A by Type (2020-2031)
Figure 60. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price (USD/Unit) by Type (2020-2031)
Figure 61. Global Sales Market Share of Tumor Necrosis Factor Receptor Superfamily Member 1A by Application (2020-2031)
Figure 62. Global Revenue Market Share of Tumor Necrosis Factor Receptor Superfamily Member 1A by Application (2020-2031)
Figure 63. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price (USD/Unit) by Application (2020-2031)
Figure 64. Tumor Necrosis Factor Receptor Superfamily Member 1A Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
